| +974 4003 3333
Tawfeg Ben-Omran

Tawfeg Ben-Omran 
^ null
FRCPC,MBCHB

Division Chief - Genetic and Genomic Medicine Years Of Experience: 27

  • About the Physician

    Dr. Tawfeg Ben-Omran is the Division Chief of Genetics and Genomic Medicine at Sidra Medicine, a women’s and children’s hospital in the State of Qatar.

    Dr. Ben-Omran’s clinic provides comprehensive genetic services including clinical evaluation and risk assessment; genetic counselling; diagnosis and the advanced management for a variety of genetic disorders in pediatric patients of all ages. The clinic also offers ongoing multidisciplinary care for patients with genetic conditions and helps them access resources and treatment programs personalized to their condition.

    The clinic also offers genetic counselling in partnership with the Qatar National Premarital Genetic Screening Program. Other key services include preimplantation genetic diagnosis and prenatal genetic testing and diagnosis and Inborn Errors of Metabolism.

     

    Languages Spoken

    English, Arabic

    Years Of Experience
    27
    Education
    • Medical degree from Al Arab Medical University in Libya and his residency in clinical and metabolic genetics from the Hospital of Sick Children in Canada.
    • Fellow of the Royal College of Physicians and Surgeons of Canada; the Canadian College of Medical Genetics and is also a corresponding fellow from the American College of Medical Genetics and Genomics.
    Affiliations
    • Associate Professor at Weill-Cornell Medicine Qatar and a distinguished visiting scientist at Boston Children’s Hospital in the USA.
    • Member of Hamad Medical Corporation’s National Newborn Screening Committee and National Premarital Genetic Screening program.
    Areas of Interest
    • genetics
    • genomic medicine
    • inborn errors of metabolism
    • genetic counselling
    Medical Publications
    1. Farber Disease Mimicking Juvenile Idiopathic Arthritis: The First Reported Case in Qatar and Review of the Literature.
    2. Expanding on the phenotypic spectrum of Woodhouse-Sakati syndrome due to founder pathogenic variant in DCAF17: Report of 58 additional patients from Qatar and literature review.
    3. Epileptic encephalopathy caused by ARV1 deficiency: Refinement of the genotype-phenotype spectrum and functional impact on GPI-anchored proteins.